- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01132144
Endometrial Injury for Assisted Reproduction
Endometrial Injury Prior Ovulation Induction for Assisted Reproductive Techniques: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Sao Paulo
-
Ribeirao Preto, Sao Paulo, Brazil, 14049-900
- Setor de Reproducao Humana do HC-FMRP-USP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women who will start assisted reproductive techniques with planned fresh embryo transfer.
- Age between 18 and 38 years.
- Written informed consent.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Endometrial injury group
Endometrial biopsy was performed once with a pipelle de Cornier® in the month before initiating controlled ovarian stimulation.
|
Evaluate the position and size of the uterus by transabdominal ultrasonography, with the bladder comfortably full. Identify the cervix with a disposable speculum. Open one sealed opaque envelope for allocation. Endometrial injury:
|
Sham Comparator: Control group
Introduction of the speculum and wiping of the cervix with gaze for 30 seconds.
|
The investigator will dry the cervix with gauze and forceps for for 30 seconds or until participant ask for stopping.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Live Birth
Time Frame: 1 year
|
The complete expulsion or extraction from its mother of a product of fertilization, irrespective of the duration of the pregnancy, which, after such separation, breathes or shows any other evidence of life, such as heart beat, umbilical cord pulsation, or definite movement of voluntary muscles, irrespective of whether the umbilical cord has been cut or the placenta is attached. Note: All allocated women will be used as denominator when assessing live birth rate. |
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Pregnancy
Time Frame: 3 months
|
Pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy. It includes ectopic pregnancy. Multiple gestational sacs are counted as one clinical pregnancy. Note: All allocated women will be considered when assessing clinical pregnancy rate. |
3 months
|
Ongoing Pregnancy
Time Frame: 6 months
|
At least one fetus with heart beat after 12 weeks of gestational age. Note: All allocated women will be considered when assessing ongoing pregnancy rate. |
6 months
|
Miscarriage
Time Frame: 9 months
|
Loss of a clinical pregnancy before 20 completed weeks of gestational age (18 weeks after fertilization). Note: All allocated women will be considered when assessing miscarriage rate. |
9 months
|
Implantation Rate
Time Frame: 3 months
|
The number of gestational sacs observed divided by the number of embryos transferred.
|
3 months
|
Endometrial Thickness
Time Frame: 1 month
|
The maximum distance perpendicular to the inter-endometrial interface from the endometrium-myometrium interface of the anterior to the posterior wall of the uterus assessed in the sagittal plane.
This outcome will be assessed when at least one follicle ≥ 17mm is observed.
|
1 month
|
Endometrial Volume
Time Frame: 1 month
|
The total volume of endometrial tissue assessed by three-dimensional ultrasonography.
This outcome will be assessed when at least one follicle ≥ 17mm is observed.
|
1 month
|
Three-dimensional Doppler Indices From Endometrium (VFI)
Time Frame: 1 month
|
Vascularization index (VI), flow index (FI) and vascularization-flow index (VFI) assessed from endometrium using three-dimensional Power Doppler ultrasonography. This outcome will be assessed when at least one follicle ≥ 17mm is observed. Only VFI was reported as it is a combination of VI and FI (VFI = VI*FI/100), and currently there are several concerns about the validity of these indices. Such indices have no scale. |
1 month
|
Procedure Related Pain
Time Frame: Immediately after procedure
|
Pain will be assessed using a Visual Analogue Scale (VAS). We will use a 10 cm length horizontal line, anchored by word descriptors at each end: "No Pain" = 0 cm and "Very Severe Pain" = 10 cm. This outcome will be assessed in both groups, just after endometrial injury or sham procedure. |
Immediately after procedure
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wellington P Martins, PhD, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HCRP10340/09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Endometrial injury
-
University of AarhusUnknown
-
The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
University of Sao PauloTerminated
-
Mansoura UniversityUnknown
-
Mansoura UniversityUnknownInfertility | Polycystic Ovarian SyndromeEgypt
-
University of Sao PauloConselho Nacional de Desenvolvimento Científico e TecnológicoTerminated
-
McGill UniversityUnknown
-
Ain Shams Maternity HospitalUnknown
-
National and Kapodistrian University of AthensCompletedHysteroscopy | Endometrial Injury | Repeated Implantation FailuresGreece
-
Mansoura Integrated Fertility CenterCompletedUnexplained Infertility